New patent for Catalyst Pharms drug FYCOMPABy DrugPatentWatch – Make Better Decisions / March 19, 2024 Annual Drug Patent Expirations for FYCOMPA Fycompa is a drug marketed by Catalyst Pharms and is included in two NDAs. It is available from two suppliers. There are two patents…Source